An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
HIV Infection, Pregnancy
About this trial
This is an interventional health services research trial for HIV Infection focused on measuring Pregnancy, Prevention of Mother to Child Transmission, Short Message Service (SMS), HIV infection, CD4 testing, Antiretroviral therapy
Eligibility Criteria
Study was conducted and intervention was implemented in antenatal clinics. Criteria for clinic participation:
Inclusion Criteria:
- Clinic providing antenatal services within greater Gaborone, Botswana
- CD4 specimens analyzed at Botswana Harvard HIV Reference Laboratory
- Supervising authority provided written permission for participation
Exclusion Criteria:
- Facilities caring for incarcerated women
- Facilities without a dedicated antenatal program
Endpoints assessed in pregnant women meeting the following criteria:
Inclusion Criteria:
- Delivered at Princess Marina Hospital
- Documented HIV infection
- Botswana citizen
Exclusion Criteria:
- Receiving HAART prior to antenatal clinic registration
Sites / Locations
- Botswana Harvard AIDS Institute
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Tokafatso programmatic intervention
Usual Care
Antenatal clinic receives the Tokafatso programmatic intervention, including educational session, SMS-based facilitation of CD4 result delivery, and patient tracing support.
Has not yet received Tokafatso combination programmatic intervention